Thesis
The histone deacetylase inhibitor panobinostat as a radiosensitiser in bladder cancer
- Abstract:
-
Muscle invasive bladder cancer (MIBC) has a poor prognosis. Currently, therapy consists of radical radiotherapy or cystectomy with or without chemotherapy. The average age of patients with MIBC is high and older patients are less able to tolerate surgery or chemoradiation due to their impaired physical fitness and generally poor renal function. There is an urgent need to find new treatment regimes that are both tolerable and effective.
Expand abstract
Actions
Authors
Contributors
+ Kiltie, A
Division:
MSD
Department:
Oncology
Role:
Supervisor
+ Kerr, M
Division:
MSD
Department:
Oncology
Role:
Supervisor
Funding
+ Slovene Human Resources Development and Scholarship Fund; Cancer Research UK
More from this funder
Funding agency for:
Groselj, B
Bibliographic Details
- Publication date:
- 2014
- Type of award:
- DPhil
- Level of award:
- Doctoral
- Awarding institution:
- Oxford University, UK
Item Description
- Language:
- English
- Keywords:
- Subjects:
- UUID:
-
uuid:40f48d00-8d74-41db-8630-ceacf22f3e78
- Local pid:
- ora:9789
- Deposit date:
- 2015-01-22
Terms of use
- Copyright holder:
- Groselj, B
- Copyright date:
- 2014
- Notes:
- This thesis is not currently available in ORA.
If you are the owner of this record, you can report an update to it here: Report update to this record